Last Price
0.139
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Paul V. Goode Ph.D. Mr. Paul V. Goode Ph.D.
Full Time Employees: 6 6
IPO Date: 2013-04-25 2013-04-25
CIK: 0001506983 0001506983
ISIN: US45824Q5071 US45824Q5071
CUSIP: 45824Q507 45824Q507
Beta: 0.16 0.16
Last Dividend: 0.00 0.00
Dcf Diff: -0.66 -0.66
Dcf: 1.03 1.03
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.